A B S T R A C T Chlamydia trachomatis
INTRODUCTION
Chlamydia trachomatis has been recovered from the urethra from 30-50% of men with nongonococcal urethritis (NGU)l (1) (2) (3) (4) , and from a significantly lower proportion of controls without urethritis (1, 2) , or with gonorrhea (1) . Serologic evidence suggests chlamydia infection is recently acquired in many men with NGU (1, 5, 6) . Chlamydia can be recovered from the endocervix of sex partners of most NGU patients with chlamydia infection, but seldom from sex partners of NGU patients without chlamydia infection (3). Persistence or recurrence of urethritis within 1-6 wk after completion of 7 days' therapy with tetracycline is significantly more common for chlamydia-negative NGU (47%) than for chlamydia-positive NGU (17%) (7) .
The etiology of chlamydia-negative NGU has not been elucidated by previous qualitative analysis of the urethral flora of men with and without NGU (1) , but Ureaplasma urealyticuim (8) and Hemophiltus vaginalis (9, 10) have been suspected to be possible causes of NGU. Previous studies indicate 22-90% of NGU cases respond to sulfonamide therapy (11) (12) (13) (14) (15) (16) .
'Abbreviations used in this paper: CCU, color changing units; IFA, immunofluorescent antibody; NGU, nongonococcal urethritis.
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Since C. trachomatis is sensitive to sulfonamide (17) , while U. urealyticum (18) and H. vaginalis are resistant to stulfonamides (19) , the present study was undertaken to compare the response of chlamydiapositive and chlamydia-negative NGU to sulfisoxazole. We reasoned that if chlamydia-positive NGU responded to sulfisoxazole while chlamydia-negative NGU did not, this wouild support the etiologic role of C. trachomatis in NGU and wouild stuggest that the causative agent(s) of chlamydia-negative NGU was a sulfonamide-resistant organism. Quantitative cultures for H. vaginalis and U. uirealyticum were performed in conjunction with the therapeutic trial, together with urethral ctultures for C. trachomatis, and testing of paired sera for immitnofluiorescent antibody to C. trachomnatis and complement-dependent uireaplasmacidal antibody to U. uirealyticum. The prevalence of H. vaginalis and U. utrealyticum was compared in men with chlamydia-positive NGU, chlamydia-negative NGU, and men with no urethritis. To minimize the occurrence of uirethral colonization or serum antibody related to previouis NGU, men who had previouisly had uirethritis were excluded from this stuidy.
METHODS
Study population. Cauicasian males attending the Seattle King Couinty Venereal Disease Clinic with complaints of discharge and (or) dysuiria, and who had a demonstrable uirethral exudate were accepted into this stuidy if they were tnder 36 yr of age, had never had NGU or gonorrhea or symptoms suggestive of uirethritis, had not taken antimicrobials in the preceding 3 mo, had three or less sex partners in the preceding 3 mo, had not had symptoms longer than 1 mo, were not allergic to stulfonamides, had negative Gram stain and cultuLre of urethral exudate for Neisseria gonorrhoeae, and had pyturia demonstrated as described below.
Men attending the same clinic who fulfilled the same criteria except that they had no symptoms and signs of uirethritis or pyuria formed a "no urethritis" comparison group. Written consent was obtained from all men in the study. Pretreatment evaluiation. At the initial visit, men in both the NGU and the no urethritis grouips uinderwent a standardized interview concerning demography, sexual history, veneral disease history, and present illness; examination of the genitalia, and inguiinal lymph nodes; and careful inspection of the bulbar and palpebral conjutnctiva. (y-chain specific). Antibody titer was expressed by the reciprocal of the highest serum dilution which resulted in definite immunofluorescence, a titer of <8 was considered a negative reaction. Seroconversion or a titer rise of fourfold or greater in paired sera was considered significant.
Complement-dependent mycoplasmacidal antibody to 11 strains of U. urealyticum was measured as previously described (25) , except that the serum was not dialyzed before use.
Quantitative determination of antibody to gonococcal pili was performed as previously described (26) , except that protein A containing staphylococcus was used in the place of the second antibody to human IgG. With this modification, we have found serum antibody concentrations 2 1 ,ug/ml to be correlated with the presence of gonococcal infection.
Statistical analysis. The proportions of groups affected by selected variables were compared with Fisher's exact test (27) with n c 60 and Chi square analysis with Yates correction (28) with n > 60. Mean and standard deviation of series of data were compared by Student's t test (29) . RESULTS 69 men with NGU and 39 men with no urethritis were studied. 13 of those with no urethritis had other sexually transmitted genital diseases, while 26 attended the clinic for routine examination. Men with NGU were similar to those with no urethritis with respect to mean years of age±+1 SD (23.0+4.1 vs.
23.2+3.6), mean years of education (14.0+1.7 vs. 14.4+2.0), and mean age of first intercourse (17.2 +2.3 vs. 17.8+2.6, P > 0.20). Those with NGU had a lower median number of total sex partners than those with no urethritis (4.8 vs. 8.0). 41 of 67 NGU patients and 11 of 35 men with no urethritis had c5 total sex partners (X2 = 5.87, P < 0.025).
C. trachomatis isolation and serology. C. trachomatis was recovered from the urethra of 23 (33%) of 69 NGU patients and 1 of the 39 with no urethritis (P < 0.001). C. trachomatis was recovered from 4 The remaining 10 patients with NGU not shown in Fig. 1 had only a single serum tested. None of three from whom chlamydia were isolated had detectable IFA, and one of seven chlamydia-culture-negative patients had detectable IFA (titer 1:8). 5 The results ofthe quantitative cultures for U. urealyticum in the first voided urine are shown in Table II . U. urealyticum was isolated in a concentration of 2 103 CCU/ml first voided urine from 22 (52%) of 42 men with C. trachomatis-negative NGU, three (12%) of 26 with C. trachomatis-positive NGU (P < 0.005), and 8 (21%) of 39 with no urethritis (P < 0.025).
The difference between chlamydia-negative NGU patients and men with no urethritis, in terms of qualitative isolations of U. urealyticum, is greater if patients are grouped or matched according to thWeir total number of sex partners. Among men who had had intercourse with 5 women or less during their lifetime, U. urealyticum was recovered from 22 (92%) of 24 with chlamydia-negative NGU and 3 (23%) of 13 with no urethritis (P < 0.002) and 8 (50%) of 16 with chlamydiapositive NGU (P < 0.01). It was also possible to consecutively match, in the order that they were admitted to the study, 20 chlamydia-negative NGU patients with 20 patients with no urethritis exactly for total number of lifetime sex contacts and for age +2 yr. U. urealyticum was recovered from 17 of 20 chlamydia-negative NGU patients and from 9 of 20 matched controls with no urethritis (P < 0.02).
Sera obtained from men receiving antimicrobials active against ureaplasma (e.g. tetracycline or spectinomycin) were excluded from the studies of ureaplasmacidal antibody. A fourfold rise or fall in titer of complement-dependent ureaplasmacidal antibody was de- [3] [4] [5] [6] [7] [8] days after starting therapy were negative for chlamydia in all 22 intitially chlamydia-culture-positive men followed. In contrast, U. urealytictutr was recovered at 7-12 days from 22 (92%) of 24 patients who were initially ureaplasma-positive, and from 2 (14%) of 14 who were initially ureaplasmanegative before treatment.
The results of sulfisoxazole therapy were correlated with the chlamydia status by culture and serology and with the pretreatment cultures for ureaplasma. As shown in Table IV , a complete or partial resolution of objective signs of urethritis was seen at 7-12 days in 21 (88%) of 24 chlamydia-positive and 18 (49%) of 37 chlamydia-negative patients (P <0.01). The three chlamydia-positive patients who showed no response included both of the patients who had .106 CCU/ml of U. turealyticum and one with 10' CCU/ml. A complete or partial response was seen in 22 (54%) of 41 ureaplasma-positive and 17 (85%) of 20 ureaplasma-negative patients (P < 0.05).
A complete or partial response was observed in 13 (100%) of 13 chlamydia-positive, ureaplasma-negative cases and 14 (47%) of 30 chlamydia-negative, uireaplasma-positive cases (P < 0.002).
A high rate of recurrence of chlamydia-negative sulfonamide non-responsive NGU was noted after subsequent tetracycline therapy. 20 patients who showed no objective response, and 10 who showed a partial response after 10 days therapy with sulfisoxazole were treated with tetracycline 500 mg four times daily for 7 days. 29 returned for followup at the end of 1 wk of tetracycline therapy and all were significantly improved. Within the next 4 wk, 12 of 17 (71%) sulfonamide failures, and 4 of 9 who had responded partially to sulfonamide required further retreatment after the course of tetracycline because of recurrence of urethral discharge and (or) pyuria. At the time of initiation of the second retreatment, seven who had originally been ureaplasma positive were again recultured and ureaplasma was again recovered from five of the seven. reactivate a latent chlamydial infection (2) . If this were true, then C. trachomatis would be present coincidentally or as a secondary pathogen. The results of sulfisoxazole therapy suggest that most cases of chlamydia-negative NGU were caused by a sulfonamide resistant organism. Handsfield et al. previously showed that 4 (31%) of 13 men with chlamydiaculture-negative NGU had resolution or improvement in urethral discharge and pyuria within 0-3 days after completion of 1 wk therapy with placebo (7) . Thus, sulfonamide was not much more effective than placebo for chlamydia-negative NGU.
No evidence for urethral gonococcal infection was provided by duplicate Gram-stained smears, cultures on two media, or by serologic testing for antipili antibody.
Urethral infection with U. urealyticum, but not with H. vaginalis, was associated with chlamydia-negative NGU. Since the initial discovery of U. urealyticum 740 Bowie et al. by Shepard in 1954 (31) , the role of this organism in NGU has been debated, as summarized by McCormack et al. (8) . In the present study, the demonstration of an association between urethral U. urealyticum infection and NGU may be attributable to, (1) selection of patients with no past history of urethritis, (2) separation of cases of NGU into chlamydiapositive and chlamydia-negative groups, (3) quantitative cultures for U. urealyticum, (4) matching of patients with chlamydia-negative NGU with patients having no urethritis with respect to age, race and total number of sex partners, and (5) separate analysis of patients who had had .5 sex partners.
It should be noted that the differences in ureaplasma isolation between men with chlamydia-negative NGU and men with no urethritis could be explained if first voided urine specimens are less sensitive in detecting urethral ureaplasma infection in men with no urethritis than in men with urethritis, as has been suggested by Tarr et al. (32) . However, the potential objection should not account for the difference observed between men with urethritis, in this case the chlamydia positive and chlamydia negative NGU groups. We have not found a difference between isolation techniques in other studies on 81 men with urethritis who had both an endourethral swab and a first voided urine obtained for ureaplasma culture; we found ureaplasma in both cultures in 52, in the swab alone in 2, and the urine alone in 3. If there is an increase in isolation of ureaplasma with an increase in pyuria, and if chlamydia negative men have more pyuria, this could possibly account for some portion of the increased isolatism rate of ureaplasma in chlamydia-negative men. Chlamydia-negative men did not have significantly more pyuria than chlamydia-positive men in this study, but Holmes et al.
(1) have previously demonstrated the association when a larger group of men was studied.
In a previous study in Seattle, U. urealyticum was not recovered more often from men with chlamydia-negative NGU than from those with chlamydiapositive NGU or with no urethritis. In that study, however, patients with prior urethritis or many sex partners were not excluded, and quantitative mycoplasma cultures were not employed (1) . If U. urealyticum causes NGU, it is necessary to explain why these organisms are so often recovered from sexually active men with no urethritis. Perhaps U. urealyticum produces urethritis only in certain individuals, but in most is carried chronically without causing inflammation. Multiple serotypes of U. urealyticum have been demonstrated by metabolic-inhibition, mycoplasmacidal, and other serological tests (18) . It is possible that only certain pathogenic strains are associated wth NGU, or that only the initial infection with any new strain could produce urethritis in a susceptible individual. Any of the above possibilities could explain why an association of U. urealyticum with chlamydia-negative NGU was best demonstrated for individuals with fewest total number of sex partners. Such individuals would be most likely to be encountering U. urealyticurm for the first time, since the prevalence of urethral U. urealyticum infection in men is correlated with total number of previous sex partners (33) .
Previous therapeutic trials have shown that the tetracyclines and erythromycin are effective in the treatment of NGU (34, 35) , while lincomycin (36) and the penicillins (11, 37, 38) are not. These results are consistent with either chlamydia or ureaplasma etiology, since both C. trachomatis and U. urealyticum are high susceptible to tetracycline and erythromycin but are relatively resistant to the penicillins and lincomycin (17, 18, 39, 40) in vitro. The therapeutic response to sulfisoxazole in the present study is consistent with separate chlamydia and ureaplasma etiologies. Ureaplasma is susceptible in vitro to spectinomycin (41) which has only slight activity against C. trachomatis. In another study (42) , we have found that spectinomycin is significantly more effective for treatment of ureaplasma-positive, chlamydia-negative NGU than for ureaplasma-negative, chlamydia-positive NGU. In that study only 1 of 14 men given spectinomycin for chlamydia-positive NGU was improved 7-14 days after starting therapy. Furthermore, Handsfield et al. (7) found that only 1 of 10 men with chlamydia isolation positive NGU improved within 7-10 days during placebo therapy. Thus, the improvement of chlamydia positive NGU in 21 of 24 men given sulfisoxazole in the present study cannot be attributed to the natural course of the disease.
The present study establishes an association of U. uirealyticum only with initial episodes of NGU, and does not prove the association is causal. Previous serologic studies have generally failed to show rises in serum antibody titers to ureaplasma in men with NGU (43) (44) (45) . In the present study, even among men with high titers of ureaplasma in first voided uirine, a ureaplasmacidal antibody response was uncommon. Further support for ureplasma etiology could be sought by cohort study, experimental inoctulation, and perhaps by new serologic techniques.
